BVS
Bioventus Inc.
$11.88
-0.34 (-2.78%)
At close · Jul 10
Market Cap
$992.39M
Shares
83,534,785
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$568.09M
-0.9%
FY2025
Net Income
$22.73M
+167.8%
FY2025
Gross Margin
68.33%
+0.6pp
FY2025
Operating Margin
9.5%
+11.6pp
FY2025
Diluted EPS
$0.33
+163.5%
FY2025
Operating Cash Flow
$74.67M
+92.5%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|---|
| $600M – $610M | $576.3M | $568.09M | $573.28M | $512.35M | $512.12M | $430.9M | |
| — | $180.43M | $179.93M | $185.05M | $184.15M | $181.04M | $128.19M | |
| — | $395.87M | $388.16M | $388.23M | $328.19M | $331.08M | $302.71M | |
| — | — | 68.33% | 67.72% | 64.06% | 64.65% | 70.25% | |
| — | $11.57M | $12.11M | $13.64M | $13.45M | $25.94M | $19.04M | |
| — | $318.85M | $314.03M | $340.89M | $303.88M | $332.61M | $254.25M | |
| — | — | $38.98M | $39.02M | $45.24M | $67.04M | $35.48M | |
| — | $46.35M | $47.01M | $49.56M | $57.37M | $66.8M | $34.88M | |
| — | — | $2.24M | -$52K | $840K | $6.78M | $2.49M | |
| — | $57.52M | $53.98M | -$11.98M | -$81.73M | -$251.05M | $12.06M | |
| — | — | 9.5% | -2.09% | -15.95% | -49.02% | 2.8% | |
| — | $103.87M | $100.99M | $37.58M | -$24.36M | -$184.25M | $46.94M | |
| — | -$23.88M | -$28.27M | -$37.15M | -$39.39M | -$12.85M | -$4.44M | |
| — | $33.64M | $25.71M | -$49.13M | -$121.11M | -$263.9M | $7.62M | |
| — | -$899K | -$1.57M | -$5.29M | $85K | -$50.51M | -$1.97M | |
| — | $28.48M | $22.73M | -$33.54M | -$156.23M | -$158.7M | $19.38M | |
| — | — | 4% | -5.85% | -30.49% | -30.99% | 4.5% | |
| — | — | -$10.92M | — | — | -$54.69M | -$9.79M | |
| — | — | — | — | — | -$158.7M | — | |
| — | $28.27M | $23.41M | -$36.91M | -$155.33M | -$158.99M | $18.12M | |
| USD/shares | — | — | $0.34 | -$0.52 | -$2.49 | -$2.59 | -$0.15 |
| USD/shares | — | — | $0.33 | -$0.52 | -$2.49 | -$2.59 | -$0.15 |
| shares | — | — | 66.62M | 64.55M | 62.65M | 61.39M | 45.47M |
| shares | — | — | 68.91M | 64.55M | 62.65M | 61.39M | 45.47M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
2.13×
Medical Devices median 2.38×
EV/EBIT
21.36×
Medical Devices median 21.54×
P/E (TTM)
28.98×
Medical Devices median 26.77×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| US Segment | $502,097,000 | $506,809,000 | $449,860,000 | $455,251,000 |
| International Segment | $65,990,000 | $66,471,000 | $62,485,000 | $56,866,000 |
By Geography (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|
| United States | $502,097,000 | $506,809,000 | $449,860,000 | $455,251,000 | $387,553,000 | $293,697,000 | $305,072,000 |
| Non Us | $65,990,000 | $66,471,000 | $62,485,000 | $56,866,000 | $43,345,000 | $27,464,000 | $35,069,000 |
By Product & Service (USD)
| Component | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|
| Pain Treatments | $221,607,000 | $171,178,000 | $182,082,000 |
| Restorative Therapies | $121,572,000 | $88,624,000 | $103,504,000 |
| Surgical Solutions | $87,719,000 | $61,359,000 | $54,555,000 |